ASCO Renal Cancer. Current Clinical Issues & Future Trends

The renowned Breast Cancer expert Dr. Tim Eisen and the editor-in-chief of the series, Dr. Pere Gascón, selected the most recently published information by ASCO on the advances in the management of Renal Cancer and they evaluate their impact on daily clinical practice. Recent information is offered on the cancer cell hypothesis, the prognostic value of intratumoral neutrophils, the emerging new molecular classification, the anti-angiogenic agents, the therapeutic approaches metastatic disease, etc. This extraordinary and completely updated self-assessment program is offered in a collection of three volumes in both online and print formats. Self-Assessment questions are included at the end of each volume.

• Volume 1: Pathophysiology of Renal Cancer. 92 pages.
• Volume 2: Early & Advanced Disease. Prognostic and Predictive Factors. Immunotherapy for Renal Cancer. 92 pages.
• Volume 3: Advances in Treatment of the Metastatic Disease. 96 pages.